1 Reason I'm Still Keeping an Eye on UPS Stock, Despite Recent Lows

United Parcel Service (UPS) is undergoing a strategic recalibration to counter significant stock declines (32% YTD, 60% from pandemic highs) driven by increased labor costs and margin compression. The company is actively shedding lower-margin business, including a strategic reduction in its partnership with Amazon, to focus on higher-margin clients. A key growth driver is its expanding healthcare logistics segment, which generated $10.5 billion in 2024 and targets $20 billion by 2026 through acquisitions like Bomi and Andlauer, positioning it for potential profitability improvements and a stock turnaround as healthcare clients prioritize reliability over cost.

Analysis

United Parcel Service (UPS) is undergoing a significant strategic recalibration amid substantial stock price depreciation, with shares falling 32% year-to-date and 60% from pandemic-era highs. The decline is attributed to margin compression from increased labor costs and weaker U.S. volumes. In response, management is pivoting away from high-volume, low-margin business, notably reducing its partnership with Amazon, which constituted 11.8% of 2024 revenue. The core of this turnaround strategy is an aggressive expansion into higher-margin healthcare logistics. This segment, which generated $10.5 billion in 2024, is targeted to reach $20 billion in revenue by 2026, bolstered by acquisitions like Bomi and Andlauer Healthcare that enhance temperature-controlled service capabilities. The rationale is that healthcare clients prioritize delivery reliability and sensitivity over cost, offering a pathway to improved profitability and a potential reversal of the stock's downward trajectory from its currently depressed valuation.

Key Decisions for Investors

• Evaluate UPS as a potential turnaround investment, given the stock's significant price decline and the clear strategic pivot towards higher-margin healthcare and B2B segments.
• Closely monitor the revenue growth and margin contribution from the healthcare logistics division relative to its ambitious $20 billion target by 2026, as this is the primary catalyst for the bull thesis.
• Investors should weigh the near-term risk of revenue and volume declines from shedding major accounts like Amazon against the long-term potential for margin expansion from the new strategic focus.
• Note that while the turnaround narrative is compelling, some external analyses cited in the article remain cautious, suggesting that execution risk is high or better opportunities may exist elsewhere.